The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), announced $14.9 million in funding for a new Integrative Cancer Biology Program (ICBP). The ICBP is a unique initiative designed to gain new insights into the development and progression of cancer through a system-wide approach. An integrative and multi-disciplinary effort among all […]

Increasing mammography screening rates and investing in research to improve breast cancer detection technologies should be top priorities, according to authors of a study published in the October 20, 2004, Journal of the National Cancer Institute*. As many as 92 percent of late-stage breast cancer cases in the United States could be diagnosed and treated […]

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, found no convincing evidence that breast implants have an effect on the development of subsequent connective tissue disorders (CTDs). The results are reported in the October 1, 2004 issue of the American Journal of Epidemiology.*

The National Institutes of Health (NIH) today announced new funding for the Transdisciplinary Tobacco Use Research Centers (TTURC) initiative, which originally awarded grants to seven research centers in 1999. This new investment, totaling almost $12 million, will be funded over the next five years by the National Institute on Drug Abuse (NIDA), the National Institute […]

A three-year study to validate a test to detect the recurrence of bladder cancer has been initiated by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), at 13 centers* across the United States and Canada. This test was conceived and is being conducted by NCI’s Early Detection Research Network (EDRN). […]

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have used artificial neural networks (ANNs) and DNA microarrays to successfully predict the clinical outcome of patients diagnosed with neuroblastoma (NB). The ANNs also identified a minimal set of 19 genes whose expression levels were closely associated with this clinical […]